{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T09:04:26Z","timestamp":1724663066237},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.thromres.2013.06.021","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T03:47:07Z","timestamp":1373341627000},"page":"e86-e93","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association of the JAK2 46\/1 haplotype with non-splanchnic venous thrombosis"],"prefix":"10.1016","volume":"132","author":[{"given":"Katja","family":"Zerjavic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Zagradisnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidija","family":"Lokar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjana G.","family":"Krasevac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja K.","family":"Vokac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.06.021_bb0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Jones","year":"2009","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.thromres.2013.06.021_bb0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ng.341","article-title":"A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms","volume":"41","author":"Olcaydu","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.thromres.2013.06.021_bb0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.342","article-title":"A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms","volume":"41","author":"Kilpivaara","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.thromres.2013.06.021_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.thromres.2013.06.021_bb0025","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/leu.2009.110","article-title":"The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera","volume":"23","author":"Olcaydu","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2013.06.021_bb0030","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2009-08-236448","article-title":"The JAK2 46\/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms","volume":"115","author":"Jones","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.06.021_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/leu.2009.226","article-title":"The JAK2 46\/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients","volume":"24","author":"Pardanani","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2013.06.021_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/leu.2009.225","article-title":"JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46\/1 haplotype is associated with inferior survival","volume":"24","author":"Tefferi","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2013.06.021_bb0045","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/leu.2010.126","article-title":"Frequency and clinical correlates of JAK2 46\/1 (GGCC) haplotype in primary myelofibrosis","volume":"24","author":"Guglielmelli","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2013.06.021_bb0050","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/leu.2010.172","article-title":"JAK2 46\/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia","volume":"24","author":"Andrikovics","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2013.06.021_bb0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1538-7836.2009.03691.x","article-title":"The JAK2 rs12343867 CC genotype frequently occurs in patients with splanchnic venous thrombosis without the JAK2V617F mutation: A retrospective study","volume":"8","author":"Colaizzo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.06.021_bb0060","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1182\/blood-2010-11-319087","article-title":"European Network for Vascular Disorders of the Liver (EN-Vie). The JAK2 46\/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis","volume":"117","author":"Smalberg","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.06.021_bb0065","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1182\/blood-2011-03-343657","article-title":"The JAK2 46\/1 haplotype in splanchnic vein thrombosis","volume":"117","author":"Kouroupi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.06.021_bb0070","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.leukres.2011.08.008","article-title":"JAK2 46\/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms","volume":"36","author":"Villani","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.thromres.2013.06.021_bb0075","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2141.2008.07537.x","article-title":"Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms","volume":"144","author":"Za","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.06.021_bb0080","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1182\/blood-2007-11-125328","article-title":"The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases","volume":"111","author":"Kiladjian","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.06.021_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1538-7836.2007.02811.x","article-title":"Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism","volume":"6","author":"Ugo","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.06.021_bb0090","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2007.02424.x","article-title":"Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders","volume":"5","author":"De Stefano","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.06.021_bb0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jmg.2006.048371","article-title":"Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings","volume":"44","author":"Colaizzo","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.thromres.2013.06.021_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000314645","article-title":"Is the JAK2 V617F mutation a hallmark for different forms of thrombosis?","volume":"124","author":"Zerjavic","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1016\/j.thromres.2013.06.021_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00277-011-1233-0","article-title":"Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg","volume":"91","author":"Lauw","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.thromres.2013.06.021_bb0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4065\/83.4.457","article-title":"JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients","volume":"83","author":"Pardanani","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.thromres.2013.06.021_bb0115","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/sj.leu.2404710","article-title":"JAK2V617F prevalence and allele burden in nonsplanchnic venous thrombosis in the absence of overt myeloproliferative disorder","volume":"21","author":"Pardanani","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2013.06.021_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bcmd.2010.07.004","article-title":"JAK2 46\/1 haplotype seems not to be associated with lower limb deep venous thrombosis","volume":"45","author":"Trifa","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.thromres.2013.06.021_bb0125","doi-asserted-by":"crossref","first-page":"E88-8","DOI":"10.1093\/nar\/29.17.e88","article-title":"An efficient procedure for genotyping single nucleotide polymorphisms","volume":"29","author":"Ye","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.thromres.2013.06.021_bb0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"10.1016\/j.thromres.2013.06.021_bb0135","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00277-010-0960-y","article-title":"The G allele of the JAK2 rs10974944 SNP, part of JAK2 46\/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms","volume":"89","author":"Trifa","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.thromres.2013.06.021_bb0140","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3324\/haematol.2011.043885","article-title":"The prognostic impact of germline 46\/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia","volume":"96","author":"Nahajevszky","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2013.06.021_bb0145","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/sj.onc.1203925","article-title":"Janus kinases: components of multiple signaling pathways","volume":"19","author":"Rane","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.thromres.2013.06.021_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)00398-0","article-title":"Signaling through the JAK\/STAT pathway, recent advances and future challenges","volume":"285","author":"Kisseleva","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.thromres.2013.06.021_bb0155","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2013.06.021_bb0160","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.exphem.2007.01.053","article-title":"V617F JAK2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules","volume":"35","author":"Falanga","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.thromres.2013.06.021_bb0165","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1538-7836.2007.02626.x","article-title":"Platelet and coagulation activation markers in myeloproliferative diseases: relationship with JAK2 V617F status, clonality, and antiphospholipid antibodies","volume":"5","author":"Robertson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.06.021_bb0170","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano-Rodrigo","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2013.06.021_bb0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13353-012-0125-x","article-title":"The influence of novel transcriptional regulatory element in intron 14 on the expression of Janus kinase 2 gene in myeloproliferative neoplasms","volume":"54","author":"Spasovski","year":"2013","journal-title":"J Appl Genet"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813002727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813002727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T03:45:39Z","timestamp":1715658339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813002727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0049384813002727"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.06.021","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of the JAK2 46\/1 haplotype with non-splanchnic venous thrombosis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}